Top

Netherlands Heart Journal

Gepubliceerd in:

01-08-2011 | Original Article

Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict

Auteurs: M. C. Post, W. Budts, A. Van de Bruaene, R. Willems, B. Meyns, F. Rega, M. Gewillig

Gepubliceerd in: Netherlands Heart Journal | Uitgave 7-8/2011

Abstract

Aims

We evaluate the incidence of epicardial lead failure and try to identify risk factors in patients with congenital heart disease.

Methods

All patients with a congenital heart defect and an epicardial pacing system, implanted within a timeframe of 25 years, were included in this study. Patients’ medical records and lead data were reviewed. Lead failure was defined as the primary endpoint.

Results

In total 198 active epicardial leads (atrial 40, ventricular 158) were implanted in 93 patients (median age at implantation 4.4 years (range 0–58.6)). During a total follow-up of 1235 lead-years, 29 lead failures (14.6%, 4 atrial, 25 ventricular) were documented in 22 patients (23.7%). Lead failure occurred at a median time period of 4.8 years (range 1.2–24.1) after implantation. Five-year freedom of lead failure was 88%. The only independent predictor for lead failure was the age at implantation (HR 0.44; 95%CI 0.20–0.97, p = 0.04), other characteristics failed to predict lead failure. Sudden cardiac death occurred in four patients (4.3%), in one a lead failure was documented.

Conclusion

A high incidence of epicardial lead failures is found in patients with congenital heart disease. Unfortunately, it is difficult to predict this potentially life-threatening complication.

vorige artikel GRACE and TIMI risk scores but not stress imaging predict long-term cardiovascular follow-up in patients with chest pain after a rule-out protocol

volgende artikel The role of multi-slice computed tomography in stable angina management: a current perspective

Fortescue EB, Berul CI, Cecchin F, et al. Comparison of modern steroid-eluting epicardial and thin transvenous pacemaker leads in pediatric and congenital heart disease patients. J Interv Card Electrophysiol. 2005;14:27–36.PubMedCrossRef

Beaufort-Krol GC, Mulder H, Nagelkerke D, et al. Comparison of longevity, pacing, and sensing characteristics of steroid-eluting epicardial versus conventional endocardial pacing leads in children. J Thorac Cardiovasc Surg. 1999;117:523–8.PubMedCrossRef

Ector B, Willems R, Heidbuchel H, et al. Epicardial pacing: a single-centre study on 321 leads in 138 patients. Acta Cardiol. 2006;61:343–51.PubMedCrossRef

Cohen MI, Bush DM, Vetter VL, et al. Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation. 2001;103:2585–90.PubMed

Silvetti MS, Drago F, Grutter G, et al. Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace. 2006;8:530–6.PubMedCrossRef

Murayama H, Maeda M, Sakurai H, et al. Predictors affecting durability of epicardial pacemaker leads in pediatric patients. J Thorac Cardiovasc Surg. 2008;135:361–6.PubMedCrossRef

ten Udink CF, Breur J, Boramanand N, et al. Endocardial and epicardial steroid lead pacing in the neonatal and paediatric age group. Heart. 2002;88:392–6.CrossRef

Tomaske M, Gerritse B, Kretzers L, et al. A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children. Ann Thorac Surg. 2008;85:1704–11.PubMedCrossRef

Sachweh JS, Vazquez-Jimenez JF, Schondube FA, et al. Twenty years experience with pediatric pacing: epicardial and transvenous stimulation. Eur J Cardiothorac Surg. 2000;17:455–61.PubMedCrossRef

10.

Horenstein MS, Hakimi M, Walters III H, et al. Chronic performance of steroid-eluting epicardial leads in a growing pediatric population: a 10-year comparison. Pacing Clin Electrophysiol. 2003;26:1467–71.PubMedCrossRef

11.

Fortescue EB, Berul CI, Cecchin F, et al. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm. 2004;1:150–9.PubMedCrossRef

12.

Cutler NG, Karpawich PP, Cavitt D, et al. Steroid-eluting epicardial pacing electrodes: six year experience of pacing thresholds in a growing pediatric population. Pacing Clin Electrophysiol. 1997;20:2943–8.PubMedCrossRef

13.

Crossley GH, Brinker JA, Reynolds D, et al. Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead. A randomized, controlled study. Model 4068 Investigators. Circulation. 1995;92:2935–9.PubMed

14.

Johns JA, Fish FA, Burger JD, et al. Steroid-eluting epicardial pacing leads in pediatric patients: encouraging early results. J Am Coll Cardiol. 1992;20:395–401.PubMedCrossRef

Titel: Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict
Auteurs: M. C. Post
W. Budts
A. Van de Bruaene
R. Willems
B. Meyns
F. Rega
M. Gewillig
Publicatiedatum: 01-08-2011
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 7-8/2011
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-011-0158-5

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Aims

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 7-8/2011

GRACE and TIMI risk scores but not stress imaging predict long-term cardiovascular follow-up in patients with chest pain after a rule-out protocol

Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience

A young man with near-syncope

Spontaneous resolution of mid-segment coronary vasospasm previously unresponsive to intracoronary nitroglycerin

Severe transient left ventricular dysfunction induced by thyrotoxicosis

Chest pain without ST elevation: a continuing challenge